curatedBladderData |
Clinically Annotated Data for the Bladder Cancer Transcriptome |
GSE13507_eset |
Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer. |
GSE1827_eset |
Bladder cancer outcome and subtype classification by gene expression. |
GSE19915.GPL3883_eset |
Combined gene expression and genomic profiling define two intrinsic molecular subtypes of urothelial carcinoma and gene signatures for molecular grading and outcome. |
GSE19915.GPL5186_eset |
Combined gene expression and genomic profiling define two intrinsic molecular subtypes of urothelial carcinoma and gene signatures for molecular grading and outcome. |
GSE31189_eset |
A candidate molecular biomarker panel for the detection of bladder cancer. |
GSE31684_eset |
Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer. |
GSE32894_eset |
A molecular taxonomy for urothelial carcinoma. |
GSE37317_eset |
Transcriptional signatures of Ral GTPase are associated with aggressive clinicopathologic characteristics in human cancer. |
GSE5287_eset |
Emmprin and survivin predict response and survival following cisplatin-containing chemotherapy in patients with advanced bladder cancer. |
GSE89_eset |
Identifying distinct classes of bladder carcinoma using microarrays. |
PMID17099711.GPL8300_eset |
Regional copy number-independent deregulation of transcription in cancer. |
PMID17099711.GPL91_eset |
Regional copy number-independent deregulation of transcription in cancer. |